These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 1304531)

  • 1. [Role of carboplatin in treating patients with advanced ovarian cancer].
    Pawlicki M; Koralewski P
    Ginekol Pol; 1992 Aug; 63(8):416-9. PubMed ID: 1304531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of carboplatin in ovarian cancer. Current results and thoughts for the future.
    Ozols RF
    Acta Obstet Gynecol Scand Suppl; 1992; 155():75-7. PubMed ID: 1502894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carboplatin reinduction after taxane in patients with platinum-refractory epithelial ovarian cancer.
    Kavanagh J; Tresukosol D; Edwards C; Freedman R; Gonzalez de Leon C; Fishman A; Mante R; Hord M; Kudelka A
    J Clin Oncol; 1995 Jul; 13(7):1584-8. PubMed ID: 7602347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term follow-up of the first randomized study of cisplatin versus carboplatin for advanced epithelial ovarian cancer.
    Taylor AE; Wiltshaw E; Gore ME; Fryatt I; Fisher C
    J Clin Oncol; 1994 Oct; 12(10):2066-70. PubMed ID: 7931475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platinum - sensitive relapsed epithelial ovarian cancer: not all the patients benefit from reinduction with carboplatin and paclitaxel.
    Milović-Kovačević M; Stamatovic L; Popov I; Radošević-Jelić L; Kezic I
    Med Sci Monit; 2010 Nov; 16(11):CR549-54. PubMed ID: 20980960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Continued chemosensitivity to cisplatin/carboplatin in ovarian carcinoma despite treatment with multiple prior platinum-based regimens.
    Markman M; Kennedy A; Webster K; Kulp B; Peterson G; Belinson J
    Gynecol Oncol; 1997 Jun; 65(3):434-6. PubMed ID: 9190971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pegylated liposomal doxorubicin combined with carboplatin: a rational treatment choice for advanced ovarian cancer.
    Pignata S; Lauraine EP; du Bois A; Pisano C
    Crit Rev Oncol Hematol; 2010 Jan; 73(1):23-30. PubMed ID: 19782576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intraperitoneal cisplatin and carboplatin in the management of ovarian cancer.
    Markman M
    Semin Oncol; 1994 Apr; 21(2 Suppl 2):17-9; quiz 20, 58. PubMed ID: 8202717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carboplatin and pegylated liposomal doxorubicin for advanced ovarian cancer: preliminary activity results of the MITO-2 phase III trial.
    Pignata S; Scambia G; Savarese A; Breda E; Sorio R; Pisano C; Lorusso D; Cognetti F; Vernaglia Lombardi A; Gebbia V; Scollo P; Morabito A; Signoriello G; Perrone F
    Oncology; 2009; 76(1):49-54. PubMed ID: 19039248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A phase II study of modified dose-dense paclitaxel and every 4-week carboplatin for the treatment of advanced-stage primary epithelial ovarian, fallopian tube, or peritoneal carcinoma.
    Abaid LN; Micha JP; Rettenmaier MA; Brown JV; Mendivil AA; Lopez KL; Goldstein BH
    Cancer Chemother Pharmacol; 2013 Jul; 72(1):101-7. PubMed ID: 23660691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Whole-body hyperthermia (WBH) in combination with carboplatin in patients with recurrent ovarian cancer - a phase II study.
    Atmaca A; Al-Batran SE; Neumann A; Kolassa Y; Jäger D; Knuth A; Jäger E
    Gynecol Oncol; 2009 Feb; 112(2):384-8. PubMed ID: 19059635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advanced ovarian cancer: a clinical update on first-line treatment, recurrent disease, and new agents.
    Ozols RF
    J Natl Compr Canc Netw; 2004 Sep; 2 Suppl 2():S60-73. PubMed ID: 19780247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carboplatin/paclitaxel versus cisplatin/paclitaxel as first-line chemotherapy in advanced ovarian cancer: an interim analysis of a randomized phase III trial of the Arbeitsgemeinschaft Gynäkologische Onkologie Ovarian Cancer Study Group.
    du Bois A; Lück HJ; Meier W; Möbus V; Costa S; Richter B; Warm M; Bauknecht T; Schröder W; Olbricht S; Nitz U; Jackisch C
    Semin Oncol; 1997 Oct; 24(5 Suppl 15):S15-44-S15-52. PubMed ID: 9346222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paclitaxel with carboplatin versus paclitaxel with carboplatin alternating with cisplatin as first-line chemotherapy in advanced epithelial ovarian cancer: preliminary results of a Hellenic Cooperative Oncology Group study.
    Skarlos DV; Aravantinos G; Kosmidis P; Athanassiadis A; Stathopoulos GP; Pavlidis N; Bafaloukos D; Karphathios S; Papakostas P; Bamia C; Fountzilas G
    Semin Oncol; 1997 Oct; 24(5 Suppl 15):S15-57-S15-61. PubMed ID: 9346224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. One year maintenance of carboplatin in patients with epithelial ovarian cancer--a phase II study.
    Safra T; Kovner F; Barak N; Inbar MJ; Ron IG
    Isr Med Assoc J; 2006 Jan; 8(1):27-9. PubMed ID: 16450747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Responses to salvage chemotherapy in ovarian cancer: a critical need for precise definitions of the treated population.
    Markman M; Hoskins W
    J Clin Oncol; 1992 Apr; 10(4):513-4. PubMed ID: 1548513
    [No Abstract]   [Full Text] [Related]  

  • 17. Intraperitoneal chemotherapy with carboplatin and interferon alpha in the treatment of relapsed ovarian cancer: a pilot study.
    Repetto L; Chiara S; Guido T; Bruzzone M; Oliva C; Ragni N; Conte PF; Rosso R
    Anticancer Res; 1991; 11(4):1641-3. PubMed ID: 1746921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Study of high doses of carboplatin as a first choice in the therapy of advanced ovarian cancers].
    Kerbrat P; Héron JF; Guastalla JP; Lhomme C; Goupil A; Toussaint C; Rey A; Chazard M; Lenaz L; George M
    Bull Cancer; 1991; 78(12):1133-7. PubMed ID: 1786426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytogenetic analysis of carboplatin resistance in early-stage epithelial ovarian carcinoma.
    Osterberg L; Levan K; Partheen K; Helou K; Horvath G
    Cancer Genet Cytogenet; 2005 Dec; 163(2):144-50. PubMed ID: 16337857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Results of reinduction therapy with paclitaxel and carboplatin in recurrent epithelial ovarian cancer.
    Gronlund B; Høgdall C; Hansen HH; Engelholm SA
    Gynecol Oncol; 2001 Oct; 83(1):128-34. PubMed ID: 11585424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.